News

Archegos Founder Requests Home Confinement in Sentencing Appeal

Archegos Founder Requests Home Confinement in Sentencing Appeal

Bill Hwang's Legal Maneuvering for Reduced Sentence

Bill Hwang, the figure behind Archegos Capital Management, is preparing for a crucial court appearance where he aims to appeal his substantial prison term. Hwang is seeking a reduction of his 18-year sentence, proposing that a significant portion be served in home confinement.

Upcoming Court Hearing

The hearing is set to unfold in a New York courthouse on an upcoming Thursday. Hwang's attorney, Barry Berke, will advocate for a modification to Hwang's sentence, suggesting that it be adjusted to 11 1/2 years in prison complemented by 6 1/2 years of home confinement. This request emerges amid growing health concerns and potential placement in a higher-security prison that accommodates serious offenders.

Overview of Hwang's Case

The legal saga surrounding Hwang has captivated financial circles, especially after his July conviction for orchestrating a fraudulent scheme aimed at banks. His actions facilitated the accumulation of billions in trading capacity for Archegos, leading to heightened valuations that ultimately collapsed in March 2021. This downfall resulted in a staggering loss of around $10 billion for banks engaged in trades with him.

Judicial Considerations

The possibility of Judge Alvin Hellerstein reconsidering Hwang’s sentence presents a surprising turn in the legal proceedings. It's anticipated he may deliver a decision directly from the bench on whether to accept Hwang’s plea for a modified sentence.

Prosecution's Stance Against Home Confinement

The prosecution remains firm in its position against the proposed changes to Hwang's sentence. Federal prosecutors assert that applicable laws do not permit a split sentence that would allow Hwang to serve years of his term at home. They emphasize that he is likely to transition to a minimum-security facility operated by the US Bureau of Prisons after serving the initial four years and expect him to move to a halfway house post a decade.

Concerns Over Wealth and Justice

Prosecutors have also voiced their concern that permitting a wealthy individual like Hwang to avoid a more extended prison sentence could convey a misaligned message regarding justice. They stress the importance of equitable treatment for offenders across the spectrum of similar financial crimes.

Delayed Imprisonment for Hwang

Regardless of the outcome of the court's deliberations, it appears that Hwang's entry into prison would remain postponed. Judge Hellerstein has granted Hwang the privilege to stay free while an appeal is anticipated, which could extend over the course of a year or more.

Frequently Asked Questions

What is Bill Hwang seeking in court?

Bill Hwang is asking to reduce his 18-year prison sentence to include home confinement for part of that time.

Why is Hwang's attorney arguing for home confinement?

His attorney cites health issues and the risk of being placed in a high-security facility as reasons for the request.

What was Hwang convicted of?

Hwang was convicted of defrauding banks through a scheme that resulted in substantial financial losses for them.

What could the judge decide?

The judge may choose to grant or deny Hwang's request for a modified sentence, potentially ruling from the bench.

When is the court hearing scheduled?

The court hearing is planned for a Thursday in New York.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles